Ketogenic Diet
Very low carbohydrate, high fat diet that shifts metabolism to ketone utilization for fuel.
Evidence Summary
Among the most-studied dietary protocols, with robust evidence for weight loss, glycemic control and lipid changes in type 2 diabetes and an established therapeutic role in drug-resistant epilepsy. A 2025 meta-analysis of 17 randomized controlled trials (1,197 participants with type 2 diabetes; Frontiers in Nutrition) found a ketogenic/very-low-carbohydrate diet lowered HbA1c by 0.36%, fasting glucose by 10.7 mg/dL, triglycerides by 19.9 mg/dL and body weight by 3.7 kg versus control diets, while modestly raising HDL cholesterol (+2.5 mg/dL); the change in LDL was small and not statistically significant. A 2024 NHANES cohort of 43,776 adults (Scientific Reports) linked a higher dietary ketogenic ratio to 24% lower all-cause mortality (HR 0.76) with no significant change in cardiovascular mortality. Longevity data remain associational, and a subset of hyper-responders see LDL rise, so periodic lipid monitoring and an individualized, often cyclical approach are advised. Not appropriate for everyone.
Evidence Scale
Mechanism of Action
Carbohydrate restriction depletes hepatic glycogen and lowers circulating insulin, driving hepatic ketogenesis. The ketone body beta-hydroxybutyrate (BHB) then serves both as an efficient alternative fuel and as a signaling molecule — inhibiting class I histone deacetylases (HDACs), helping to dampen NLRP3-inflammasome activity and oxidative stress, and improving mitochondrial efficiency and insulin sensitivity.
Who Is This For?
Metabolic flexibility, neurological conditions, weight loss, mental clarity. Requires commitment and monitoring.
Protocol & Dosing
Dose
Carbs <20-50g/day. Fat 70-80% of calories. Protein moderate. Transition period 2-4 weeks.
Frequency
Daily
Duration
Cyclical or ongoing
Protocol Summary
Carbohydrates under 20-50 g daily, fat 70-80% of calories, moderate protein (15-20%). Expect a 2-4 week adaptation period (keto flu); prioritize sodium, potassium and magnesium to ease it. Track ketones during adaptation and monitor a lipid panel (especially LDL and ApoB) periodically. Cyclical or targeted variants suit many people; individualize under clinical guidance.
Latest Evidence
2024-2025: stronger metabolic and mortality data for the ketogenic diet
A 2025 meta-analysis of 17 randomized controlled trials (1,197 participants with type 2 diabetes; Frontiers in Nutrition) found that a ketogenic / very-low-carbohydrate diet, versus control diets, lowered HbA1c by 0.36% (95% CI −0.44 to −0.29), fasting glucose by 10.7 mg/dL, triglycerides by 19.9 mg/dL and body weight by 3.7 kg, while modestly raising HDL cholesterol (+2.5 mg/dL). The change in LDL cholesterol was small (+2.6 mg/dL) and not statistically significant.
A 2024 analysis of 43,776 U.S. adults in NHANES (Scientific Reports) linked a higher dietary ketogenic ratio to 24% lower all-cause mortality (HR 0.76, 95% CI 0.63-0.90) with no significant change in cardiovascular mortality (HR 1.13, 95% CI 0.79-1.60). These build on the diet’s established therapeutic role in drug-resistant epilepsy and its consistent short-to-medium-term benefits for weight and glycemic control.
Longevity findings are associational, not proof of cause; a subset of hyper-responders see LDL/ApoB rise, so periodic lipid monitoring, adequate electrolytes and an individualized, often cyclical approach are advised. Not appropriate for everyone (see contraindications). Educational information, not medical advice.
Meta-analysis · mean difference vs control diet (mg/dL) · 17 RCTs
Ketogenic diet vs control: lower glucose and triglycerides, higher HDL
Bars show the pooled mean difference in each blood marker for a ketogenic / very-low-carbohydrate diet versus control diets; whiskers are 95% confidence intervals and the dashed line marks no change. Triglycerides and fasting glucose fall well below zero (benefit) and HDL rises modestly (benefit), while LDL cholesterol changes little and the effect is not statistically significant. HbA1c fell 0.36% and body weight 3.7 kg in the same analysis (different units, not shown). Source: 2025 systematic review and meta-analysis of 17 randomized controlled trials in 1,197 patients with type 2 diabetes (Frontiers in Nutrition). Educational information, not medical advice.
Related on Peak Human
Intermittent Fasting
Companion protocol that also raises ketones.
Type 2 Diabetes
Where the glycemic evidence is strongest.
Weight Loss
Appetite, insulin and fat-loss mechanisms.
Longevity
Ketogenic ratio and all-cause mortality.
Magnesium Glycinate
Electrolyte support during keto adaptation.
Nutrition at Peak Human
How we personalize dietary protocols.
Optimization
Physician-guided metabolic and biomarker optimization.
Peak Human Shop
Electrolytes and metabolic support supplements.
Key references: Effects of a low-carbohydrate diet on glucose and lipid metabolism in overweight/obese type 2 diabetes — meta-analysis of RCTs, Frontiers in Nutrition (2025) · Dietary ketogenic ratio and all-cause & cardiovascular mortality (NHANES, 43,776 adults) — Scientific Reports (2024) · Very-low-carbohydrate (ketogenic) diets in type 2 diabetes — systematic review & meta-analysis of RCTs, Diabetes, Obesity & Metabolism (Wiley) · Ketogenic Diet — Clinical Applications and Evidence-based Indications, StatPearls / NCBI
Interactions & Precautions
Contraindications
- Type 1 diabetes (careful supervision)
- Pancreatitis
- Gallbladder disease
- Severe liver disease
Potential Risks
- •Adaptation challenges
- •Social difficulties
- •Potential nutrient gaps
- •LDL elevation in some
Potential Side Effects
Practitioner Notes
Clinical annotations from Dr. Goel
Not for everyone. Consider cyclical approach. Monitor LDL (hyper-responders). Electrolytes critical. Therapeutic for some conditions, optional for others.
Dr. Sanjeev Goel
Chief Medical Officer, Peak Human
Cost & Access
Cost Range
$
Accessibility
Availability varies by location
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation